Recalled heart devices often lack clinical testing, researchers found in a study published last week in the Annals of Internal Medicine. Heart devices account for one-third of Class I recalls, the Food and Drug Administration’s most serious designation. Researchers found the recalled devices “were infrequently subjected to premarket or postmarket testing, with recalls affecting thousands of patients annually.”